Sort   by:  
 Page size 
UnknownStress-induced changes in CARF expression determine cell fate to death, survival, or malignant transformation.
Not available
S-EPMC7193007 | biostudies-literature
UnknownRat Glioma Cell-Based Functional Characterization of Anti-Stress and Protein Deaggregation Activities in the Marine Carotenoids, Astaxanthin and Fucoxanthin.
Not available
S-EPMC6470788 | biostudies-literature
UnknownCARF enrichment promotes epithelial-mesenchymal transition via Wnt/β-catenin signaling: its clinical relevance and potential as a therapeutic target.
Not available
S-EPMC5945778 | biostudies-literature
UnknownMarine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence.
Not available
S-EPMC6627158 | biostudies-literature
UnknownMolecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides.
Not available
S-EPMC8188803 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownAspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213 | biostudies-literature
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
Sort   by:  
 Page size